SG11202004661QA - Antimicrobial peptides and methods of using same - Google Patents

Antimicrobial peptides and methods of using same

Info

Publication number
SG11202004661QA
SG11202004661QA SG11202004661QA SG11202004661QA SG11202004661QA SG 11202004661Q A SG11202004661Q A SG 11202004661QA SG 11202004661Q A SG11202004661Q A SG 11202004661QA SG 11202004661Q A SG11202004661Q A SG 11202004661QA SG 11202004661Q A SG11202004661Q A SG 11202004661QA
Authority
SG
Singapore
Prior art keywords
methods
same
antimicrobial peptides
antimicrobial
peptides
Prior art date
Application number
SG11202004661QA
Inventor
Michael Kuhn
Richard Ewin
Derek Sheehan
Eric Baima
Christopher Zook
Hilary Phelps
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of SG11202004661QA publication Critical patent/SG11202004661QA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A01N37/46—N-acyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
SG11202004661QA 2017-12-07 2018-12-05 Antimicrobial peptides and methods of using same SG11202004661QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762595725P 2017-12-07 2017-12-07
PCT/US2018/064029 WO2019113181A1 (en) 2017-12-07 2018-12-05 Antimicrobial peptides and methods of using same

Publications (1)

Publication Number Publication Date
SG11202004661QA true SG11202004661QA (en) 2020-06-29

Family

ID=65003464

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202004661QA SG11202004661QA (en) 2017-12-07 2018-12-05 Antimicrobial peptides and methods of using same

Country Status (19)

Country Link
US (2) US11352396B2 (en)
EP (1) EP3720875A1 (en)
JP (1) JP7381465B2 (en)
KR (2) KR20230110822A (en)
CN (1) CN111479824A (en)
AR (1) AR113618A1 (en)
AU (2) AU2018378035B2 (en)
BR (1) BR112020009973A2 (en)
CA (1) CA3082491A1 (en)
CL (1) CL2020001464A1 (en)
CO (1) CO2020006907A2 (en)
IL (1) IL275074A (en)
MX (1) MX2020005920A (en)
NZ (1) NZ764838A (en)
PH (1) PH12020550942A1 (en)
SG (1) SG11202004661QA (en)
TW (3) TW202116348A (en)
WO (1) WO2019113181A1 (en)
ZA (1) ZA202003387B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112023019519A2 (en) * 2021-03-23 2023-10-31 Genvor Inc ANTIMICROBIAL PEPTIDES
CN113185576B (en) * 2021-04-09 2023-05-30 倪京满 Beta-hairpin type low-toxicity broad-spectrum antibacterial peptide with RRRF corner and application thereof
WO2023108026A2 (en) 2021-12-08 2023-06-15 Oakgrove Bio Llc Biological production of histidine-rich peptides
EP4198045A1 (en) * 2021-12-16 2023-06-21 Université de Lille Antimicrobial peptides, variants and chemical analogues thereof and their uses
WO2024003890A1 (en) * 2022-06-29 2024-01-04 Omnix Medical Ltd. Novel peptide for treating an infectious disease or condition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1323166C (en) * 2003-09-18 2007-06-27 中国农业科学院饲料研究所 Method of improving king crab element gene with higher antibacterial activity and high effect expression
CN101307316B (en) 2008-07-22 2011-03-16 北京中农颖泰生物技术有限公司 Secretion expression of antibiotic peptide CAD in bacillus subtilis and expression system of recombination bacillus subtilis
CN101698682B (en) 2009-10-26 2012-05-23 陕西省微生物研究所 Double-functional fusion protein based on antibacterial peptide, preparation method and applicaitoin thereof
CN101817883B (en) 2010-03-12 2012-06-13 广东药学院 Housefly cecropin-human lysozyme fusion protein, and preparation method and application thereof
CN101851620B (en) 2010-04-21 2012-05-23 吉林农业大学 Method for producing FGFs by utilizing edible medicinal fungus
CA2890357C (en) 2011-07-13 2024-01-09 Solarvest BioEnergy Inc. Methods and uses of a modified cecropin for treating endoparasitic and bacterial infections
CN104177502B (en) * 2014-08-21 2018-04-24 天津兰瑞生物技术有限公司 A kind of histone-antibody fusion protein and preparation method
CN104988170B (en) * 2015-08-01 2018-01-16 吉林农业大学 One kind fusion antibacterial peptide and its preparation method and application

Also Published As

Publication number Publication date
EP3720875A1 (en) 2020-10-14
IL275074A (en) 2020-07-30
WO2019113181A1 (en) 2019-06-13
AU2018378035A1 (en) 2020-05-28
AR113618A1 (en) 2020-05-20
TWI746908B (en) 2021-11-21
CA3082491A1 (en) 2019-06-13
CN111479824A (en) 2020-07-31
TW202204376A (en) 2022-02-01
AU2018378035B2 (en) 2023-06-15
PH12020550942A1 (en) 2021-05-10
RU2020118460A (en) 2022-01-10
AU2023229465A1 (en) 2023-09-28
US11352396B2 (en) 2022-06-07
KR20230110822A (en) 2023-07-25
BR112020009973A2 (en) 2020-11-03
JP7381465B2 (en) 2023-11-15
US20200385429A1 (en) 2020-12-10
NZ764838A (en) 2023-07-28
CO2020006907A2 (en) 2020-06-19
TW201924712A (en) 2019-07-01
ZA202003387B (en) 2023-01-25
CL2020001464A1 (en) 2020-11-06
JP2021505624A (en) 2021-02-18
TWI786887B (en) 2022-12-11
US20230077604A1 (en) 2023-03-16
MX2020005920A (en) 2020-08-20
KR102555177B1 (en) 2023-07-12
KR20200074212A (en) 2020-06-24
RU2020118460A3 (en) 2022-01-10
TW202116348A (en) 2021-05-01

Similar Documents

Publication Publication Date Title
IL273432A (en) Protein degraders and uses thereof
IL273918A (en) Trispecific proteins and methods of use
EP3509615A4 (en) Stable peptides and methods of use thereof
ZA201905677B (en) Glycan-interacting compounds and methods of use
EP3255059A4 (en) Antimicrobial peptide wy-21 and use thereof
EP3274472A4 (en) Antimicrobial peptides and methods of use thereof
ZA202003387B (en) Antimicrobial peptides and methods of using same
IL268593A (en) Polypeptide variants and uses thereof
IL269236A (en) Engineered antimicrobial amphiphilic peptides and methods of use
HK1251979A1 (en) Peptide compositions and methods of use
EP3313865A4 (en) Synthetic peptide compounds and methods of use
HK1253725A1 (en) Novel antimicrobial peptide and use thereof
IL272050A (en) Synthetic proteins and therapeutic uses thereof
GB201709840D0 (en) Methods and medical uses
ZA201901942B (en) Nnif and nnif-related peptides and related methods
EP3313427A4 (en) Therapeutic peptides and methods of use thereof
EP3480212C0 (en) Il13ralpha2 peptide and its uses
EP3538541A4 (en) Preparation and use of ginsentides and ginsentide-like peptides
IL269836B (en) Substituted n-arylethyl-2-aminoquinoline-4-carboxamides and use thereof
ZA201904386B (en) S-arrestin peptides and therapeutic uses thereof
EP3630794A4 (en) Malacidins and methods of use
HUE062120T2 (en) Peptide derivative and use thereof
EP3325499A4 (en) Novel peptide and use thereof
IL269843B (en) Substituted n-arylethyl-2-arylquinoline-4-carboxamides and use thereof
HUP1700012A2 (en) Novel proteins and use thereof